NDC 62106-6903

PSORINUM

Psorinum

PSORINUM is a Oral Granule in the Human Otc Drug category. It is labeled and distributed by Seroyal Usa. The primary component is Scabies Lesion Lysate (human).

Product ID62106-6903_7d8b6c49-5d39-2350-e053-2a91aa0a09a6
NDC62106-6903
Product TypeHuman Otc Drug
Proprietary NamePSORINUM
Generic NamePsorinum
Dosage FormGranule
Route of AdministrationORAL
Marketing Start Date2018-12-21
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameSeroyal USA
Substance NameSCABIES LESION LYSATE (HUMAN)
Active Ingredient Strength200 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 62106-6903-4

10 TUBE in 1 CARTON (62106-6903-4) > 140 GRANULE in 1 TUBE
Marketing Start Date2018-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62106-6903-4 [62106690304]

PSORINUM GRANULE
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-12-21

Drug Details

Active Ingredients

IngredientStrength
SCABIES LESION LYSATE (HUMAN)200 [hp_C]/1

OpenFDA Data

SPL SET ID:7d8b6c49-5d38-2350-e053-2a91aa0a09a6
Manufacturer
UNII

NDC Crossover Matching brand name "PSORINUM" or generic name "Psorinum"

NDCBrand NameGeneric Name
0220-7604PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7622PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7623PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7624PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7625PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7626PsorinumSCABIES LESION LYSATE (HUMAN)
44911-0097PsorinumPsorinum
62106-6903PSORINUMPsorinum
64117-407PSORINUMSCABIES LESION LYSATE (HUMAN)
69152-1204Psorinum 1MPsorinum
69152-1006Psorinum 200CPsorinum

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.